Emma Urlings: A Novel Thrombin Generation Assay for Sensitive Emicizumab Monitoring
Emma Urlings, Ph.D. Candidate at Maastricht UMC+, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH, adding:
”Our manuscript is now published in Research and Practice in Thrombosis and Haemostasis!
‘Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A’
Conventional laboratory assays fall short for monitoring emicizumab in severe hemophilia A.
We developed PPP Reagent INT, a novel intrinsic pathway thrombin generation assay (TGA) reagent, and showed it is sixfold more sensitive to emicizumab levels than tissue factor-based reagents in patient plasma, with sensitivity down to very low concentration ranges relevant for dose-reduction strategies.
The choice of TGA reagent should match the mechanism of action of the treatment.
With Floor Heubel-Moenen, René van Oerle, Dave Hellenbrand, Paola van der Meijden, Tilman Hackeng, Hugo Cate, Magdolna Nagy, Henskens Yvonne and Henri Spronk.”
Title: Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A
Authors: Emma H. Urlings, Floor C.J.I. Heubel-Moenen, René van Oerle, Dave L.S. Hellenbrand, Paola E.J. van der Meijden, Tilman M. Hackeng, Hugo ten Cate, Magdolna Nagy, Yvonne M.C. Henskens, Henri M.H. Spronk
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 08:02Mud Alvi: Restarting Antithrombotic Therapy After Hemorrhagic Transformation of Ischemic Stroke
-
Sep 11, 2026, 08:01Chaza Alaji: Factor X From Inherited Deficiency to Acquired Deficiency in AL Amyloidosis
-
Sep 11, 2026, 08:01Mariusz Kowalewski: Risk Stratification of Surgical Ablation During Minimally Invasive Mitral Valve Surgery for AFib
-
Sep 11, 2026, 08:00Noor Gajraj: MTHFR Helps Turn Folate, Vitamin B9, Into The Form The Body Uses
-
Sep 11, 2026, 07:59Lisa Lacy: Living With Hereditary Antithrombin Deficiency and the Constant Threat of Clotting
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
-
Sep 10, 2026, 21:31Alejandro González Veliz: Pregnancy is a Cardiovascular Stress Test
-
Sep 10, 2026, 21:30Tareq Abadl: Did You Know That the Type of Hemoglobin in Our Blood Changes Throughout Life?